Efficacy of Glucagon-Like Peptide-1 Receptor Agonists for Psychological Well-Being and Depressive Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Weight-loss drugs don't appear to worsen depression or psychological well-being in people who take them, addressing important safety concerns for these widely used medications.
This systematic review and meta-analysis of RCTs examines the effect of GLP-1 receptor agonists on depression and psychological well-being. The findings address important safety questions about neuropsychiatric effects of these widely prescribed medications.
What the study was
- Study design
- Systematic review and meta-analysis of RCTs
- Population
- Patients on GLP-1 RAs across trials
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Human Psychopharmacology
Why it surfaced
SR/MA of GLP-1RA neuropsychiatric effects from RCTs. Addresses safety concern for widely used drugs.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.